Fig. 4
From: The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer
First ten pathways in induced tumors. A GO term enrichment analysis of biological processes that were significantly over-represented when considering differentially expressed genes in shRNA treated-tumors. B GO term enrichment analysis of biological processes that were significantly over-represented when considering differentially expressed genes in bevacizumab-treated tumors. C GO term enrichment analysis of biological processes that were significantly over-represented when considering differentially expressed genes in shRNA-plus bevacizumab-treated tumors. The remaining pathways are listed in Supplementary Table S8